Picture of Viracta Therapeutics logo

VIRX — Viracta Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Viracta Therapeutics Reports First Quarter 2021 Financial Results And Provides Clinical And Corporate Updates

May 12 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CLINICAL AND CORPORATE UPDATES
    * Q1 LOSS PER SHARE $5.22
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.21 -- REFINITIV IBES
DATA
    * VIRACTA THERAPEUTICS - CASH, EQUIVALENTS OF ABOUT $129.2
MILLION
AS OF MARCH 31, 2021
    * VIRACTA THERAPEUTICS - EXPECTS TO END 2021 WITH GREATER
THAN
$100 MILLION IN CASH, EQUIVALENTS

Source text for Eikon:  ID:nPnbncvzya 
Further company coverage:  VIRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Viracta Therapeutics

See all news